Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
ID
4084069
Author(s)
Navarini, Alexander A.; Hruz, Petr; Berger, Christoph T.; Hou, Tie Zheng; Schwab, Charlotte; Gabrysch, Annemarie; Higgins, Rebecca; Frede, Natalie; Padberg Sgier, Barbara-Christina; Kämpe, Olle; Burgener, Anne-Valérie; Marquardsen, Florian; Baldin, Fabian; Bigler, Marc; Kistner, Anne; Jauch, Annaise; Bignucolo, Olivier; Meyer, Benedikt; Meienberg, Fabian; Mehling, Matthias; Jeker, Lukas T.; Heijnen, Ingmar; Daikeler, Thomas D.; Gebbers, Jan-Olaf; Grimbacher, Bodo; Sansom, David M.; Jeker, Raphael; Hess, Christoph; Recher, Mike
Author(s) at UniBasel
Berger, Christoph Hess, Christoph Jeker, Lukas Recher, Mike Mehling, Matthias
Year
2017
Title
Vedolizumab as a successful treatment of CTLA-4-associated autoimmune enterocolitis
Journal
Journal Of Allergy And Clinical Immunology
Volume
139
Number
3
Pages / Article-Number
1043-1046.e5
Mesh terms
Adult; Antibodies, Monoclonal, Humanized, therapeutic use; Autoimmune Diseases, genetics; CTLA-4 Antigen, genetics; Enterocolitis, genetics; Gastrointestinal Agents, therapeutic use; Humans; Male; Mutation, Missense
Publisher
Elsevier
ISSN/ISBN
0091-6749 ; 1097-6825
URL
https://www.ncbi.nlm.nih.gov/pubmed/27908448
edoc-URL
https://edoc.unibas.ch/61292/
Full Text on edoc
No
Digital Object Identifier DOI
10.1016/j.jaci.2016.08.042
PubMed ID
http://www.ncbi.nlm.nih.gov/pubmed/27908448
ISI-Number
WOS:000397295800041
Document type (ISI)
Letter
MCSS v5.8 PRO. 0.383 sec, queries - 0.000 sec
©Universität Basel | Impressum
|
09/05/2024
Research Database / FORSCHUNGSDATENBANK
